DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,565 filers reported holding DANAHER CORPORATION in Q2 2020. The put-call ratio across all filers is 1.06 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,623,525 | -9.1% | 26,697 | -12.0% | 0.51% | +15.0% |
| Q2 2023 | $7,283,520 | -11.8% | 30,348 | -7.4% | 0.44% | -2.0% |
| Q1 2023 | $8,257,333 | -11.3% | 32,762 | -6.6% | 0.45% | -14.0% |
| Q4 2022 | $9,312,260 | +4.3% | 35,085 | +1.5% | 0.52% | -1.9% |
| Q3 2022 | $8,930,000 | +11.6% | 34,575 | +9.6% | 0.53% | +22.0% |
| Q2 2022 | $7,999,000 | -14.7% | 31,552 | -1.4% | 0.44% | +7.1% |
| Q1 2022 | $9,382,000 | +10.9% | 31,984 | +24.4% | 0.41% | +17.6% |
| Q4 2021 | $8,461,000 | +29.0% | 25,718 | +19.4% | 0.35% | +26.6% |
| Q3 2021 | $6,558,000 | +13.6% | 21,541 | +0.1% | 0.27% | +3.0% |
| Q2 2021 | $5,772,000 | -6.2% | 21,510 | -21.3% | 0.27% | -3.6% |
| Q1 2021 | $6,154,000 | -11.9% | 27,340 | -13.0% | 0.28% | -42.4% |
| Q4 2020 | $6,982,000 | +2.8% | 31,431 | -0.3% | 0.48% | +7.6% |
| Q3 2020 | $6,791,000 | +19.8% | 31,539 | -1.6% | 0.44% | +17.7% |
| Q2 2020 | $5,669,000 | -2.1% | 32,057 | -23.4% | 0.38% | -1.6% |
| Q1 2020 | $5,793,000 | -6.7% | 41,857 | +1.3% | 0.38% | +9.1% |
| Q4 2019 | $6,211,000 | +3.4% | 41,307 | -0.7% | 0.35% | -6.4% |
| Q3 2019 | $6,006,000 | -86.5% | 41,584 | -92.6% | 0.38% | -87.5% |
| Q2 2014 | $44,434,000 | +142.1% | 564,385 | +130.7% | 3.01% | +155.6% |
| Q1 2014 | $18,351,000 | -4.5% | 244,685 | -1.7% | 1.18% | +14.0% |
| Q4 2013 | $19,212,000 | +12.5% | 248,860 | +1.0% | 1.03% | -4.1% |
| Q3 2013 | $17,080,000 | – | 246,390 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |